Maria de Fatima Guerreiro Godoy
Research Subjects
Research Interests
Maria de Fatima Guerreiro Godoy has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Jose Maria Pereira de Godoy
Faculdade de Medicina de São José do Rio Preto (FAMERP) São José do Rio Preto São Paulo Brazil
42 shared publications - Henrique Jose Pereira de Godoy
General Practice, Clínica Godoy, São José do Rio Preto, BRA
16 shared publications - Ana Carolina Pereira de Godoy
Hospital da Criança e Materinade de Sao José do Rio Preto-Brazil, Rua Floriano Peixoto 2950, Sao José do Rio Preto, 15020010, Brazil, 55 11 949830105
8 shared publications - Lívia Maria Pereira de Godoy
Hospital Lauro De Souza Lima in Bauru, Bauru, SP, 17034-971; Clinic Godoy, São José do Rio Preto, SP, 15090-000
7 shared publications - Dalisio De Santi Neto
Hospital de Base, Medicine School in Sao Jose do Rio Preto (FAMERP), Sao Jose do Rio Preto, Brazil
3 shared publications José Maria Pereira de Godoy
Cardiovascular Surgery Department, Medicine School in São José do Rio Preto (FAMERP) and National Council for Research and Development (CNPq)
3 shared publications
Latest Publications
- Open Access
- 2 December 2025
- Published by Universidade Estadual de Maringa in Acta Scientiarum. Health Sciences
- Vol. 48, e74748
Quality of life in patients with lymphedema after treatment for breast cancer
The quality of life in patients with breast cancer has improved over the past decade. This study aimed to assess the quality of life in women with lymphedema following treatment for breast cancer. A total of 31 women with posttreatment breast cancer lymphedema, with a mean age of 61.2 years, were evaluated at Clínica Godoy in Brazil. The clinical diagnosis of lymphedema was confirmed using volumetry, perimetry, and InBody S10 bioimpedance. Lymphedema was defined by a volume increase greater than 10% compared to the contralateral limb. All participants were informed about the study and, upon consent, completed the 36-Item Short Form Survey (SF-36) quality-of-life questionnaire with appropriate guidance. Data were recorded in Excel and analyzed using Start Direct. Scores varied widely, ranging from 15 to 100. The lowest score was in the pain domain (15), while the highest median score was in social functioning (87.5); the lowest median score was in physical functioning (50). Based on Fisher’s exact test and median values, no domain showed statistically significant superiority over the others. Women with lymphedema after breast cancer treatment often experience impairment in at least one aspect of quality of life. Identifying these affected domains is essential for effective patient management.
- 2 December 2025
- Published by Universidade Estadual de Maringa in Acta Scientiarum. Health Sciences
- Vol. 48, e74748
Open AccessQuality of life in patients with lymphedema after treatment for breast cancer
The quality of life in patients with breast cancer has improved over the past decade. This study aimed to assess the quality of life in women with lymphedema following treatment for breast cancer. A total of 31 women with posttreatment breast cancer lymphedema, with a mean age of 61.2 years, were evaluated at Clínica Godoy in Brazil. The clinical diagnosis of lymphedema was confirmed using volumetry, perimetry, and InBody S10 bioimpedance. Lymphedema was defined by a volume increase greater than 10% compared to the contralateral limb. All participants were informed about the study and, upon consent, completed the 36-Item Short Form Survey (SF-36) quality-of-life questionnaire with appropriate guidance. Data were recorded in Excel and analyzed using Start Direct. Scores varied widely, ranging from 15 to 100. The lowest score was in the pain domain (15), while the highest median score was in social functioning (87.5); the lowest median score was in physical functioning (50). Based on Fisher’s exact test and median values, no domain showed statistically significant superiority over the others. Women with lymphedema after breast cancer treatment often experience impairment in at least one aspect of quality of life. Identifying these affected domains is essential for effective patient management.
- Open Access
- 1 September 2024
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 16 (9) , 436-439
Physiological Stimulus for the Synthesis of Basement Membrane Proteins Leading to Its Reconstruction
The aim of the present study was to report the remodeling of the basement membrane through physiological stimulus during the treatment of fibrosis in a lower limb with lymphedema. A clinical trial was conducted involving the evaluation of the basement membrane in skin biopsies before and after treatment for clinical stage II lower limb lymphedema using the Godoy method for the reversal of lymphedema and skin fibrosis. The samples were stained with Gomori’s reticulin stain and evaluated using Weibel’s multipoint morphometric method at the Godoy Clinic. Prior to treatment for lymphedema, rupture and important discontinuity of the basement membrane was found. After treatment, structural continuity and thickness had returned to the regions of previous rupture. The difference was statistically significant (P < 0.05, paired t-test). The present study reports that physiological stimuli targeting the lymphatic system led to the clinical reversal of fibrosis, as well as stimulate the synthesis of extracellular matrix proteins and the reconstruction of the basal lamina of the skin.
- 1 September 2024
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 16 (9) , 436-439
Open AccessPhysiological Stimulus for the Synthesis of Basement Membrane Proteins Leading to Its Reconstruction
The aim of the present study was to report the remodeling of the basement membrane through physiological stimulus during the treatment of fibrosis in a lower limb with lymphedema. A clinical trial was conducted involving the evaluation of the basement membrane in skin biopsies before and after treatment for clinical stage II lower limb lymphedema using the Godoy method for the reversal of lymphedema and skin fibrosis. The samples were stained with Gomori’s reticulin stain and evaluated using Weibel’s multipoint morphometric method at the Godoy Clinic. Prior to treatment for lymphedema, rupture and important discontinuity of the basement membrane was found. After treatment, structural continuity and thickness had returned to the regions of previous rupture. The difference was statistically significant (P < 0.05, paired t-test). The present study reports that physiological stimuli targeting the lymphatic system led to the clinical reversal of fibrosis, as well as stimulate the synthesis of extracellular matrix proteins and the reconstruction of the basal lamina of the skin.
- Open Access
- 1 July 2023
- Published by Modestum Ltd in Electronic Journal of General Medicine
- Vol. 20 (4) , em491
Multi-segment bioimpedance in the evaluation of treatment for secondary lower limb lymphedema: Gynecological cancer
Aim: The present aimed study was to report the mobilization of body fluids after five days of intensive treatment for secondary lower limb lymphedema. Materials and methods: A crossover clinical trial was conducted involving the analysis of changes in intracellular and extracellular fluids in all extremities and the trunk in women with lower limb lymphedema secondary to treatment for gynecological cancer. Evaluations were performed with multi-segment bio impedance analysis before and after intensive treatment using Godoy Method® eight hours per day for five days. Comparisons were made using Wilcoxon signed-ranks test. Results: Significant changes in intracellular and extracellular fluids were found in all extremities and the trunk (p<0.0001 for all comparisons). Conclusion: Intensive Godoy Method® leads to important changes in the distribution of body fluids in the treatment of lower limb lymphedema following treatment for gynecological cancer, with a significant increase in fluids in the upper limbs and trunk as well as significant reductions in the lower limb and in intracellular and extracellular water.
- 1 July 2023
- Published by Modestum Ltd in Electronic Journal of General Medicine
- Vol. 20 (4) , em491
Open AccessMulti-segment bioimpedance in the evaluation of treatment for secondary lower limb lymphedema: Gynecological cancer
Aim: The present aimed study was to report the mobilization of body fluids after five days of intensive treatment for secondary lower limb lymphedema. Materials and methods: A crossover clinical trial was conducted involving the analysis of changes in intracellular and extracellular fluids in all extremities and the trunk in women with lower limb lymphedema secondary to treatment for gynecological cancer. Evaluations were performed with multi-segment bio impedance analysis before and after intensive treatment using Godoy Method® eight hours per day for five days. Comparisons were made using Wilcoxon signed-ranks test. Results: Significant changes in intracellular and extracellular fluids were found in all extremities and the trunk (p<0.0001 for all comparisons). Conclusion: Intensive Godoy Method® leads to important changes in the distribution of body fluids in the treatment of lower limb lymphedema following treatment for gynecological cancer, with a significant increase in fluids in the upper limbs and trunk as well as significant reductions in the lower limb and in intracellular and extracellular water.
- Open Access
- 9 March 2023
- Published by MDPI AG in Dermatopathology
- Vol. 10 (1) , 104-111
Synthesis and Physiological Remodeling of CD34 Cells in the Skin following the Reversal of Fibrosis through Intensive Treatment for Lower Limb Lymphedema: A Case Report
A novel type of cell underwent identification between 2005 and 2008 and was denominated the “telocyte” in 2010. In 2012, transmission electron microscopy revealed the presence of telocytes in the dermis. The aim of the present study was to report important changes in immunostained CD34 cells following the treatment of lower limb lymphedema using a specific lymphatic therapy technique. A clinical trial involving the evaluation of changes in immunostained CD34 cells in the epidermis and dermis (10 randomly selected histological fields) of a patient before and after intensive treatment for clinical stage II lymphedema was conducted using the Godoy Method, which was adapted to the treatment of skin fibrosis. The evaluation involved the use of the Weibel multi-point morphometric method. Comparisons were performed using the t-test with a 95% significance level. An important increase in CD34 cells was found with redistribution occurring following treatment. The treatment of primary lymphedema of the lower limbs resulted in the clinical reversal of fibrosis and an increase in the number of immunomarked CD34 cells.
- 9 March 2023
- Published by MDPI AG in Dermatopathology
- Vol. 10 (1) , 104-111
Open AccessSynthesis and Physiological Remodeling of CD34 Cells in the Skin following the Reversal of Fibrosis through Intensive Treatment for Lower Limb Lymphedema: A Case Report
A novel type of cell underwent identification between 2005 and 2008 and was denominated the “telocyte” in 2010. In 2012, transmission electron microscopy revealed the presence of telocytes in the dermis. The aim of the present study was to report important changes in immunostained CD34 cells following the treatment of lower limb lymphedema using a specific lymphatic therapy technique. A clinical trial involving the evaluation of changes in immunostained CD34 cells in the epidermis and dermis (10 randomly selected histological fields) of a patient before and after intensive treatment for clinical stage II lymphedema was conducted using the Godoy Method, which was adapted to the treatment of skin fibrosis. The evaluation involved the use of the Weibel multi-point morphometric method. Comparisons were performed using the t-test with a 95% significance level. An important increase in CD34 cells was found with redistribution occurring following treatment. The treatment of primary lymphedema of the lower limbs resulted in the clinical reversal of fibrosis and an increase in the number of immunomarked CD34 cells.
- Open Access
- 3 November 2022
- Published by Taylor & Francis in Vascular Health and Risk Management
- Vol. ume 18, 833-838
Mortality and Deep Vein Thrombosis in the Gamma Variant of Covid 19 and Lung Injury
Purpose: The SARS-CoV-2 disease predisposes infected individuals to thrombosis, the underlying mechanisms of which are not fully understood. The balance between pro-coagulant factors and natural coagulation inhibitors in critically ill patients with Covid-19 is fundamental to the prevention and treatment of complications. The aim of the present study was to investigate the pulmonary injury patterns in Covid-19 having higher mortality in the presence of deep vein thrombosis in comparison to patients without venous thrombosis and determine the Gamma variant. Methods: A retrospective study was conducted involving the evaluation of 200 medical records of patients with Covid-19 and a clinical suspicion of deep vein thrombosis (DVT) at the intensive care unit of a public hospital. The sample was divided into two groups of patients were formed – those positive and those negative for DVT. Statistical analysis involved the use of Fisher’s exact test, the paired t-test and chi-square test. Results: Patients with DVT had more severe lung injuries (greater than 70%) compared to those without DVT (p = 0.003). Lesions affecting 50% to 70% of the lung area occurred in little more half of the group with DVT and just under half in the group without DVT (p = 0.5). Pulmonary lesions affecting less than 50% of the lung occurred more in patients without DVT (p = 0.0001). The Gamma variant increased prevalence of the both DVT and mortality (p=0.0001). Conclusion: Deep vein thrombosis is an aggravating factor of mortality in patients with SARS-CoV-2, and the Gamma variant is an aggravating factor of both thrombotic events and mortality.
- 3 November 2022
- Published by Taylor & Francis in Vascular Health and Risk Management
- Vol. ume 18, 833-838
Open AccessMortality and Deep Vein Thrombosis in the Gamma Variant of Covid 19 and Lung Injury
Purpose: The SARS-CoV-2 disease predisposes infected individuals to thrombosis, the underlying mechanisms of which are not fully understood. The balance between pro-coagulant factors and natural coagulation inhibitors in critically ill patients with Covid-19 is fundamental to the prevention and treatment of complications. The aim of the present study was to investigate the pulmonary injury patterns in Covid-19 having higher mortality in the presence of deep vein thrombosis in comparison to patients without venous thrombosis and determine the Gamma variant. Methods: A retrospective study was conducted involving the evaluation of 200 medical records of patients with Covid-19 and a clinical suspicion of deep vein thrombosis (DVT) at the intensive care unit of a public hospital. The sample was divided into two groups of patients were formed – those positive and those negative for DVT. Statistical analysis involved the use of Fisher’s exact test, the paired t-test and chi-square test. Results: Patients with DVT had more severe lung injuries (greater than 70%) compared to those without DVT (p = 0.003). Lesions affecting 50% to 70% of the lung area occurred in little more half of the group with DVT and just under half in the group without DVT (p = 0.5). Pulmonary lesions affecting less than 50% of the lung occurred more in patients without DVT (p = 0.0001). The Gamma variant increased prevalence of the both DVT and mortality (p=0.0001). Conclusion: Deep vein thrombosis is an aggravating factor of mortality in patients with SARS-CoV-2, and the Gamma variant is an aggravating factor of both thrombotic events and mortality.
- Open Access
- 25 August 2022
- Published by Springer Nature in Cureus
- Vol. 14 (8) , e28374
Reduction of Arm Lymphedema Using Manual Lymphatic Therapy (Godoy Method)
Background: The manual lymphatic drainage (MLD) technique used during the early stages following surgical treatment of breast cancer can help prevent the progression of clinical lymphedema. Objective: The objective of this study was to evaluate the effectiveness of manual lymphatic therapy (MLT) (Godoy method) in reducing the development of lymphedema immediately after breast cancer treatment. Method: A randomized, blind, crossover, clinical trial was conducted involving 66 women with breast cancer-related lymphedema (BCRL), who underwent one hour of manual physical therapy and one hour of the control procedure. To evaluate the volume before and after the application of the MLT technique, volumetry, a water displacement technique was used. For statistical analysis, the paired t-test with 5% alpha error by Stats Direct 3 (StatsDirect Ltd, Wirral, UK) was used. Results: A significant reduction in the volume of the limb was found in all patients (p-value = 0.0001, paired t-test). Conclusion: MLT is effective in reducing lymphedema after breast cancer treatment.
- 25 August 2022
- Published by Springer Nature in Cureus
- Vol. 14 (8) , e28374
Open AccessReduction of Arm Lymphedema Using Manual Lymphatic Therapy (Godoy Method)
Background: The manual lymphatic drainage (MLD) technique used during the early stages following surgical treatment of breast cancer can help prevent the progression of clinical lymphedema. Objective: The objective of this study was to evaluate the effectiveness of manual lymphatic therapy (MLT) (Godoy method) in reducing the development of lymphedema immediately after breast cancer treatment. Method: A randomized, blind, crossover, clinical trial was conducted involving 66 women with breast cancer-related lymphedema (BCRL), who underwent one hour of manual physical therapy and one hour of the control procedure. To evaluate the volume before and after the application of the MLT technique, volumetry, a water displacement technique was used. For statistical analysis, the paired t-test with 5% alpha error by Stats Direct 3 (StatsDirect Ltd, Wirral, UK) was used. Results: A significant reduction in the volume of the limb was found in all patients (p-value = 0.0001, paired t-test). Conclusion: MLT is effective in reducing lymphedema after breast cancer treatment.
- Open Access
- 8 July 2022
- Published by Springer Nature in Cureus
- Vol. 14 (7) , e26668
Mortality and Change in the Prevalence of Deep Vein Thrombosis Associated With SARS-CoV-2 P.1 Variant
Thrombosis is one of the significant challenges associated with cardiovascular diseases and a prominent cause of death globally. This study aimed to determine the monthly and overall mortality rates by sex and age group in patients hospitalized with coronavirus disease 2019 (COVID-19) and the prevalence of deep vein thrombosis (DVT) in those patients. We also investigated whether the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) P.1 variant influenced DVT. We determined the overall prevalence of COVID-19 per sex, age, and monthly mortality using hospital data at the São José do Rio Preto School of Medicine, state of São Paulo, Brazil. Data of COVID-19 patients with DVT as determined by echo-Doppler ultrasound (EDU) were analyzed by taking two time periods into account (prior to and after the onset of the predominance of the SARS-CoV-2 P.1 variant) to evaluate whether the viral variant exerted an influence on the prevalence of DVT. Patients with COVID-19 but without DVT comprised the control group. The first period was from March 2020 to February 2021, and the second was from March to June 2021. Between March 2020 and June 2021, 6,199 patients were hospitalized with COVID-19 at our institution. Of these, 2,805 (45.25%) were women and 3,376 (54.47%) were men. Two hundred fifty-four were diagnosed with DVT based on lower limb EDU. The mean mortality rate was significantly associated with sex (38.36% for men and 27.16% for women; p=0.01). The incidence of DVT in patients with COVID-19 rose significantly from 1.6% during the first study period to 7.7% during the second study period (p=0.0001), when the P.1 variant became the predominant strain. The mortality rate was significantly higher in patients with COVID-19 and DVT (58.1%) compared to the control group (33.6%; p=0.0001). Based on our findings, the incidence and prevalence of DVT increased with the predominance of P.1. viral variant. Early diagnosis and the reassessment of prophylaxis are the two most important factors to be addressed in this patient population.
- 8 July 2022
- Published by Springer Nature in Cureus
- Vol. 14 (7) , e26668
Open AccessMortality and Change in the Prevalence of Deep Vein Thrombosis Associated With SARS-CoV-2 P.1 Variant
Thrombosis is one of the significant challenges associated with cardiovascular diseases and a prominent cause of death globally. This study aimed to determine the monthly and overall mortality rates by sex and age group in patients hospitalized with coronavirus disease 2019 (COVID-19) and the prevalence of deep vein thrombosis (DVT) in those patients. We also investigated whether the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) P.1 variant influenced DVT. We determined the overall prevalence of COVID-19 per sex, age, and monthly mortality using hospital data at the São José do Rio Preto School of Medicine, state of São Paulo, Brazil. Data of COVID-19 patients with DVT as determined by echo-Doppler ultrasound (EDU) were analyzed by taking two time periods into account (prior to and after the onset of the predominance of the SARS-CoV-2 P.1 variant) to evaluate whether the viral variant exerted an influence on the prevalence of DVT. Patients with COVID-19 but without DVT comprised the control group. The first period was from March 2020 to February 2021, and the second was from March to June 2021. Between March 2020 and June 2021, 6,199 patients were hospitalized with COVID-19 at our institution. Of these, 2,805 (45.25%) were women and 3,376 (54.47%) were men. Two hundred fifty-four were diagnosed with DVT based on lower limb EDU. The mean mortality rate was significantly associated with sex (38.36% for men and 27.16% for women; p=0.01). The incidence of DVT in patients with COVID-19 rose significantly from 1.6% during the first study period to 7.7% during the second study period (p=0.0001), when the P.1 variant became the predominant strain. The mortality rate was significantly higher in patients with COVID-19 and DVT (58.1%) compared to the control group (33.6%; p=0.0001). Based on our findings, the incidence and prevalence of DVT increased with the predominance of P.1. viral variant. Early diagnosis and the reassessment of prophylaxis are the two most important factors to be addressed in this patient population.
- 14 June 2022
- Published by Bentham Science Publishers Ltd. in Current Pediatric Reviews
- Vol. 18 (3) , 179-181
Monotherapy for the Treatment of Lymphedema in Children: A Review
The Godoy Method of cervical lymphatic therapy is the first treatment option as monotherapy for children and enables achieving normalization or near normalization of the affected limb as well as the maintenance of the results, which could assist millions of children throughout the world.
- 14 June 2022
- Published by Bentham Science Publishers Ltd. in Current Pediatric Reviews
- Vol. 18 (3) , 179-181
Monotherapy for the Treatment of Lymphedema in Children: A Review
The Godoy Method of cervical lymphatic therapy is the first treatment option as monotherapy for children and enables achieving normalization or near normalization of the affected limb as well as the maintenance of the results, which could assist millions of children throughout the world.
- Open Access
- 1 February 2022
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 14 (2) , 106-107
Hypotheses and Evolution in the Current Treatment of Lipedema Syndrome
N/A J Clin Med Res. 2022;14(2):106-107 doi: https://doi.org/10.14740/jocmr4666
- 1 February 2022
- Published by Elmer Press, Inc. in Journal of Clinical Medicine Research
- Vol. 14 (2) , 106-107
Open AccessHypotheses and Evolution in the Current Treatment of Lipedema Syndrome
N/A J Clin Med Res. 2022;14(2):106-107 doi: https://doi.org/10.14740/jocmr4666
- Open Access
- 15 January 2022
- Published by Springer Nature in Cureus
- Vol. 14 (1) , e21263
Mechanical Lymphatic Drainage (RAGodoy®): Literature Review
Lymphatic drainage is the main form of therapy for lymphedema, as it affects the pathophysiology of this clinical condition. The two main objectives of lymphatic drainage are the formation and drainage of lymph. In recent years, Godoy & Godoy developed a novel concept of mechanical lymphatic drainage involving a device denominated RAGodoy®, which performs passive exercises of the lower and upper limbs as a form of lymphatic drainage. The aim of the present study was to address the concept of this therapy as well as perform a literature review on its forms of use and the results obtained. All studies analyzed show that this technique used as monotherapy enables the treatment of lymphedema, but superior results are achieved when combined with compression mechanisms.
- 15 January 2022
- Published by Springer Nature in Cureus
- Vol. 14 (1) , e21263
Open AccessMechanical Lymphatic Drainage (RAGodoy®): Literature Review
Lymphatic drainage is the main form of therapy for lymphedema, as it affects the pathophysiology of this clinical condition. The two main objectives of lymphatic drainage are the formation and drainage of lymph. In recent years, Godoy & Godoy developed a novel concept of mechanical lymphatic drainage involving a device denominated RAGodoy®, which performs passive exercises of the lower and upper limbs as a form of lymphatic drainage. The aim of the present study was to address the concept of this therapy as well as perform a literature review on its forms of use and the results obtained. All studies analyzed show that this technique used as monotherapy enables the treatment of lymphedema, but superior results are achieved when combined with compression mechanisms.